Table 5.
Correlation of preoperative inflammatory and redox biomarkers with tumor maximal dimension in testicular GCT patients.
| Laboratory Parameter | Tumor Maximal Dimension Rho/p-Value |
|---|---|
| Neutrophils (n × 109/L) | 0.175/0.107 |
| Lymphocytes (n × 109/L) | −0.038/0.730 |
| NLR | 0.174/0.110 |
| dNLR | 0.173/0.110 |
| Platelets (n × 109/L) | 0.018/0.869 |
| PLR | −0.004/0.971 |
| SII (×109/L) | 0.104/0.339 |
| SIRI (×109/L) | 0.120/0.273 |
| Monocytes (n × 109/L) | 0.094/0.389 |
| LMR | −0.041/0.711 |
| CRP (mg/L) | 0.246/0.030 * |
| AGR | −0.263/0.031 * |
| 8-OHdG (ng/mL) | 0.040/0.729 |
| Thiol groups(ng/mL) | 0.064/0.556 |
| MDA (ng/mL) | 0.160/0.162 |
NLR—neutrophil–to-lymphocytes ratio; dNLR—derived neutrophil-to-lymphocyte ratio (formula: neutrophil/(WBC-neutrophil)); PLR—platelet-to-lymphocyte ratio; SII—systemic immune-inflammation index (formula: neutrophil × platelet/lymphocyte); SIRI—systemic inflammation response index (formula: neutrophil × monocyte/lymphocyte); LMR—lymphocyte-to-monocyte ratio; CRP—C reactive protein; AGR—serum albumin/(serum total protein-serum albumin); 8-OHdG—8-hydroxy-2′-deoxyguanosine; MDA—malondialdehyde; * p < 0.05.